1) Hunner GL. A rare type of bladder ulcer in women: report of cases. Boston Med Surg J. 1915; 172: 660-4
|
|
|
2) 本間之夫. 排尿に関する疫学的研究委員会, 他. 排尿に関する疫学的研究. 日排尿機能会誌. 2003; 14: 266-77
|
|
|
3) Peeker R, et al. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000; 163: 1009-15
|
|
|
4) Parsons CL, et al. Epithelial dysfunction of in nonbacterial cystitis (interstitial cystitis). J Urol 1991; 145: 732-5
|
|
|
5) Keay S, et al. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol. 2000; 164: 2112-18
|
|
|
6) Ochs RL, et al. Autoantibodies and interstitial cystitis. Clin Lab Med. 1997; 17: 571-9
|
|
|
7) Warren JW, et al. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urol. 2008; 71: 1085-90
|
|
|
8) Christmas TJ, et al. Nerve fibre proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol. 1990; 416: 447-51
|
|
|
9) Logadottir YR, et al. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol. 2004; 171: 1148-51
|
|
|
10) Parsons CL, et al. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol. 2000; 164: 1381-4
|
|
|
11) Rosamilia A, et al. Bladder microvasculature and the effects of hydrodistension in interstitial cystitis. Urol. 2001; 57: 132
|
|
|
12) Ueda T, et al. Over expression of platelet-derived endothelial cell growth factor/ thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J Urol. 2002; 167: 347-51
|
|
|
13) Gamper M, et al. Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis. BMG Genomics. 2009; 10: 199
|
|
|
14) Ito T, et al. Interstitial cystitis in Japan. BJU Int. 2000; 86: 634-7
|
|
|
15) Oravisto KJ, et al. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975; 64: 75-7
|
|
|
16) Held PJ, et al. Epidemiology of interstitial cystitis: 2. In: Hanno PM, et al. editors. Interstitial Cystitis. New York, USA: Springer-Verlag. 1990. p. 29-48
|
|
|
17) Jones CA, et al. Prevalence of interstitial cystitis in the United States. J Urol. 1994; 151: 423A
|
|
|
18) Bade JJ, et al. Interstital cystitis in Netherlands: prevalence, diagnostic criteria and therapeutic preferences. J Urol. 1995; 154: 2035-7
|
|
|
19) Curhan GC, et al. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999; 161: 549-52
|
|
|
20) Leppilahti M, et al. Prevalence of symptom related to interstitial cystitis in women: a population based study in Finland. J Urol. 2002; 168: 139-43
|
|
|
21) Clemens JQ, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005; 173: 98-102
|
|
|
22) 伊藤貴章, 他. 本邦における間質性膀胱炎282例の臨床統計と最近の動向. 間質性膀胱炎研究会誌. 2004; 2: 19-23
|
|
|
23) Goldman HB, et al. Interstitial cystitis-the great enigma. J Urol. 2000; 164: 1921
|
|
|
24) Gillenwater JY, et al. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystits, National Institutes of Health, Bethesda, Maryland, August28-29, 1987. J URol. 1988; 140: 203-6
|
|
|
25) 日本間質性膀胱炎研究会ガイドライン作成委員会. 間質性膀胱炎診療ガイドライン. 日本間質性膀胱炎研究会ガイドライン作成委員会, 編集. 東京: ブラックウェルパブリッシング; 2007
|
|
|
26) O'Leary MP, et al. The interstitial cystitis symptom index and problem index. Urology. 1997; 49(Suppl 5A): 58-63
|
|
|
27) Lutgendorf SK, et al. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. J Urol. 2000; 164: 1265-9
|
|
|
28) Rabe HH, et al. The place of cystoscopy and hydrodistension in the diagnosis of interstitial cystitis: a potpourri of opinions emanating from an International Consultation on IC in Kyoto, Japan, March 28-30, 2003. Int J Urol. 2003; 10(Suppl): S16-8
|
|
|
29) Waxman JA, et al. Cystoscopic findings consistent with interstitial cystitis in normal women enrolled in the Interstital Cystitis Data Base (ICDB) Study. Urology. 1997; 49(Suppl1): 81-5
|
|
|
30) Rosamilia A, et al. Pathology of interstitial cystitis. Int J Urol. 2003; 10 (Suppl1): S11-5
|
|
|
31) Bumpus HC Jr, et al. Interstitial cystitis, its treatment by overdistension of the bladder. Med Clin North Am. 1930; 13: 1495-8
|
|
|
32) Greenberg E, et al. Transurethral resection of Hunner's ulcer. J Urol. 1974; 111: 764-6
|
|
|
33) Hanno PM, et al. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143-7
|
|
|
34) Ueda T, et al. Over expression of platelet-derived endothelial cell growth factor /thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J Urol. 2002; 167: 347-51
|
|
|
35) Badonoch AW. Chronic interstitial cystitis. Br J Urol. 1997; 158: 703-8
|
|
|
36) Kuo HC, et al. Comparison of intravesical botulinum toxin type A injections plus hydrodistension with hydrodistension alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. Br Int J Urol. 2009; 104: 657-61
|
|
|
37) Minogiannis P, et al. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int Immunopharmacol. 1998; 20: 553-3
|
|
|
38) Theoharides TC, et al. Hydroxyzine therapy for interstitial cystitis. Urology. 1997; 49(Suppl1): 108-10
|
|
|
39) Sant GR, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydoroxyzine in patients with interstitial cystitis. J Urol. 2003; 170: 810-5
|
|
|
40) Hanno PM, et al. Medical treatment of interstitial cystitis (other than Rimso-50/Elmiron). Urology. 1987; 29: 22-6
|
|
|
41) van Ophoven, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004; 172: 533-6
|
|
|
42) Ueda T, et al. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J Urol 2000; 164: 1917-20
|
|
|
43) Lewi H, et al. Cimetidine in the treatment of interstitial cystitis. Urology. 1995; 45: 1088
|
|
|
44) Soucy F, et al. Efficacy of predonisone for severe refractory ulcerative interstitial cystitis. J Urol. 2005; 173: 841-3
|
|
|
45) Barrington JW, et al. Pentosanpolysulfate for interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 1997; 8: 293-5
|
|
|
46) Parsons CL, et al. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol. 2002; 168: 289-92
|
|
|
47) Perez-Marrero R, et al. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988; 140: 36-9
|
|
|
48) Parsons CL, et al. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994; 73: 504-7
|
|
|
49) Morales A, et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996; 156: 45-8
|
|
|
50) Steinhoff G, et al. The efficacy of chodroitin sulfate 0. 2% in treating interstitial cystitis. Can J Urol. 2002; 9: 1454-8
|
|
|
51) Bade JJ, et al. A placebo-controlled study of intravesical pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol. 1997; 79: 168- 171
|
|
|
52) 野宮 明, 他. 間質性膀胱炎に対するヘパリン・リドカイン混合液膀胱内注入療法の検討. 間質性膀胱炎研究会会誌. 2008; 9: 20-1
|
|
|
53) Michael B, et al. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999; 162: 3-11
|
|
|
54) Christopher K, et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized double-blind, placebo controlled trial. J Urol. 2005; 173: 1590-4
|
|
|
55) Giannantoni A, et al. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow up. J Urol. 2008; 179: 1031-4
|
|
|
56) Gershbaum D, et al. Practice trend for the management of interstitial cystitis. Urology. 2001; 57: 119
|
|
|
57) Rossberger J, et al. Long-term results of reconstructive surgery in patients with bladder pain syndrome/ interstitial cystitis: subtyping is imperative. Urology. 2007; 70: 638-42
|
|
|
58) Peeker R, et al. Treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol. 1998; 159: 1479- 82
|
|
|